The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic impact of bone metastasis in urothelial carcinoma treated with first-line platinum-based chemotherapy.
 
Husam Alqaisi
No Relationships to Disclose
 
Zachary William Neil Veitch
Honoraria - Genomic Health; Pfizer/EMD Serono
 
Carlos Stecca
No Relationships to Disclose
 
Jeenan Kaiser
No Relationships to Disclose
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Pfizer; Roche Canada; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Roche Canada (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
Sunil Samnani
No Relationships to Disclose
 
Nimira S. Alimohamed
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen; Merck; Pfizer; Sanofi
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)